These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 20715508
1. [Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital]. Aoki T, Moro H, Koshio N, Tamura T, Tanabe Y, Kawai H, Matsuto T, Okada M. Rinsho Byori; 2010 Jul; 58(7):658-63. PubMed ID: 20715508 [Abstract] [Full Text] [Related]
2. [Biofilm production and antifungal susceptibility patterns of Candida species]. Yücesoy M, Karaman M. Mikrobiyol Bul; 2004 Jul; 38(1-2):91-8. PubMed ID: 15293907 [Abstract] [Full Text] [Related]
3. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. Fleck R, Dietz A, Hof H. J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369 [Abstract] [Full Text] [Related]
7. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME. Scand J Infect Dis; 2008 Apr; 40(5):414-9. PubMed ID: 18418802 [Abstract] [Full Text] [Related]
8. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. Biochem Biophys Res Commun; 2006 Aug 25; 347(2):401-5. PubMed ID: 16831406 [Abstract] [Full Text] [Related]
9. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. Clin Infect Dis; 2009 Mar 15; 48(6):e57-61. PubMed ID: 19193113 [Abstract] [Full Text] [Related]
10. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Mycoses; 2007 Jan 15; 50(1):52-7. PubMed ID: 17302749 [Abstract] [Full Text] [Related]
12. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E, Global Antifungal Surveillance Study. J Clin Microbiol; 2007 Jun 15; 45(6):1735-45. PubMed ID: 17442797 [Abstract] [Full Text] [Related]
13. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. Kucukates E, Erturan Z, Susever S, Yegenoglu Y. APMIS; 2005 Apr 15; 113(4):278-83. PubMed ID: 15865609 [Abstract] [Full Text] [Related]
20. Candidemia and the susceptibility pattern of Candida isolates in blood. Osoba AO, Al-Mowallad AW, McAlear DE, Hussein BA. Saudi Med J; 2003 Oct 15; 24(10):1060-3. PubMed ID: 14578968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]